Skip to main content

Givaudan, Amyris Expand Their Partnership

The companies’ multiyear collaboration now involves research, development and production of active cosmetics ingredients.

PARIS – Givaudan has expanded its collaboration with industrial bioscience company Amyris Inc. to research, develop and produce active cosmetics ingredients.

“The companies anticipate that the launch of target products in the coming years will demonstrate significant performance, cost and sustainability advantages over existing ingredients,” they stated on Tuesday.

Over the past several years, Givaudan has been involved with Amyris on the R&D of proprietary fragrance ingredients.

As reported, in March 2011 the Swiss flavors and fragrance supplier announced a partnership with Amyris to study the use of Biofene, a sustainable source material, to produce a key fragrance ingredient. Biofene is derived from sugar cane processing (rather than a petroleum-based chemical process, since petroleum is not a renewable resource).

“The expansion of the partnership leverages the diversity and value of Amyris’ R&D platform and manufacturing capabilities for designing high-performance, cultured ingredients,” the companies continued. “During the multiyear collaboration, Amyris will use its strain engineering platform to design cosmetic active ingredients, and scale them up at its manufacturing facility in Brotas, Brazil, for exclusive commercialization by Givaudan.”

You May Also Like

“This partnership demonstrates three concrete steps fully in line with our 2020 strategy: First, open innovation, by leveraging external partnerships; second, sustainability, by looking at different ways to source raw materials, and third, active beauty, a growing area of investment for Givaudan,” stated Maurizio Volpi, president of Givaudan’s fragrance division.

The company has been among suppliers at the forefront of implementing biotechnology and green chemistry.

Givaudan keeps developing its active-cosmetics ingredients business. In October 2015, for instance, it inaugurated a new ACI production line in Pomacle, France. The supplier invested 11 million Swiss francs, or $11.2 million at current exchange, on expanding the fermentation line, marking its largest infrastructure expenditure related to ACI.

Givaudan also strengthened its ACI muscle through the acquisitions of Induchem in August 2015 and Soliance in June 2014.